Smitha Jagadish

Director, Neuroscience/Pain - New Modalities at Grünenthal Group - Worthington, IA, US

Smitha Jagadish's Colleagues at Grünenthal Group
Dianna Morais

Human Resources Manager

Contact Dianna Morais

Bart Manning

Senior Director, Neuroscience/Pain - Translation

Contact Bart Manning

Christof Bormans

GDP-RP BeLux & NL, Senior Quality Manager BNL, EU-Business Process Expert GDP & QA

Contact Christof Bormans

Els Hollanders

Global Medical Lead Mature Brands & Early Pipeline Products

Contact Els Hollanders

View All Smitha Jagadish's Colleagues
Smitha Jagadish's Contact Details
HQ
49-241-569-0
Location
Greater Boston
Company
Grünenthal Group
Smitha Jagadish's Company Details

Grünenthal Group

Worthington, IA, US • 1000 - 4999 Employees
Major Drugs

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp

Europe: Pain (prescriptive drugs) Further indications Latin America: Pain Central Nervous System Gynecology Further indications R&D: Pain Inflammation
Details about Grünenthal Group
Frequently Asked Questions about Smitha Jagadish
Smitha Jagadish currently works for Grünenthal Group.
Smitha Jagadish's role at Grünenthal Group is Director, Neuroscience/Pain - New Modalities.
Smitha Jagadish's email address is ***@grunenthal.com. To view Smitha Jagadish's full email address, please signup to ConnectPlex.
Smitha Jagadish works in the Major Drugs industry.
Smitha Jagadish's colleagues at Grünenthal Group are Dianna Morais, Kishore Pasikanti, Bart Manning, Camille Soubrane, Christof Bormans, Marielle Eerdekens, Els Hollanders and others.
Smitha Jagadish's phone number is 49-241-569-0
See more information about Smitha Jagadish